A Comparative Study of Diane?35 plus Spironolactone and Diane ?35 Plus Finasteride in Cases of Hirsutism and Acne

Authors

A Kriplani1,*, J Thulkar2, N Agrawal2, V Kulshrestha2, AC Ammini2, G Kumar2
1Department of Obstetrics and Gynecology, [email protected], India
2Department of Obstetrics and Gynecology, India
*Corresponding Author: Department of Obstetrics and Gynecology, [email protected], India. Email: [email protected]

International Journal of Endocrinology and Metabolism:Vol. 7, issue 4; 235-241
Published online:Oct 31, 2009
Article type:Research Article
Received:Nov 14, 2008
Accepted:Nov 07, 2009
How to Cite:Kriplani A, Thulkar J, Agrawal N, Kulshrestha V, Ammini A, et al. A Comparative Study of Diane?35 plus Spironolactone and Diane ?35 Plus Finasteride in Cases of Hirsutism and Acne. Int J Endocrinol Metab. 2009;7(4):. doi:

Abstract

To compare the efficacy and safety of Diane 35 plus spironolactone and Diane 35 plus finasteride in the treatment of hirsutism and acne. Materials and Methods: A prospective randomized clinical trial was conducted on 120 Indian women with hirsutism. Group I patients were treated with Diane 35 plus spironolactone 100 mg daily and group II patients with Diane 35 plus finasteride 5 mg daily for 12 months. Hirsutism and acne score were graded every 3 months, for 18 months. The basal gonadotropins levels and androgens level were measured before the study. Statistical analysis was done by Student‘s t-test and repeated measure analysis followed by post hoc comparison. Results: Reduction in hirsutism and acne scores assessed every 3 months was significant (p<0.001) and similar between the two groups, indicating that if treatment was prolonged for over 12 months, reduction scores would have been better. A significant decrease in the hirsutism score of 55.3%±17.2 and 59.4%±17.5 was observed after 12 months in groups I and II respectively. Total reduction in hirsutism & acne scores of both groups was similar (P>0.05). Conclusion: Diane 35 plus spironolactone and Diane 35 plus finasteride are equally effective and safe in the treatment of hirsutism and acne. For better outcomes, it is recommended that the treatment period be over 12 months.

Full Text

Full text is available in PDF

Copyright

© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Jan
2021

Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-blind, Placebo-controlled, Clinical Trial

Ali Asilian,
Farahnaz Fatemi,
Zakiye Ganjei,
Amir Hossein Siadat,
Fatemeh Mohaghegh,
Mansour Siavash

Asilian A, Fatemi F, Ganjei Z, Siadat AH, Mohaghegh F, et al. Oral Pulse Betamethasone, Methotrexate, and Combination Therapy to Treat Severe Alopecia Areata: A Randomized, Double-blind, Placebo-controlled, Clinical Trial. Iran J Pharm Res. 2021;20(1):e124354. doi: https://doi.org/10.22037/ijpr.2020.113868.14536

17
Dec
2021

A Randomized, Double-blind Controlled Clinical Study to Evaluate the Efficacy and Safety of Minoxidil Topical 2% Nanosuspension with Aqueous Base in the Treatment of Androgenetic Alopecia Areata

Shahla Mirzaeei,
Ashkan Barfar,
Saba Mehrandish,
Ali Ebrahimi

Mirzaeei S, Barfar A, Mehrandish S, Ebrahimi A. A Randomized, Double-blind Controlled Clinical Study to Evaluate the Efficacy and Safety of Minoxidil Topical 2% Nanosuspension with Aqueous Base in the Treatment of Androgenetic Alopecia Areata. J Rep Pharm Sci. 2021;10(2):e146965. doi: https://doi.org/10.4103/jrptps.JRPTPS_25_21

30
Jul
2007

Comparing the Efficacy of add-on Nortryptiline With Triiodothyronine in the Management of Citalopram-Resistant Depression

Naghmeh Mokhber,
Ali Talaei

Mokhber N, Talaei A. Comparing the Efficacy of add-on Nortryptiline With Triiodothyronine in the Management of Citalopram-Resistant Depression. Iran J Psychiatry Behav Sci. 2007;1(2):. doi:

30
Sep
2004

Comparison of acid salisylic 2% and betamethasone with topical fish oil in recovery of psoriasis signs

R Ghaderi,
F Madar Shahian

Ghaderi R, Madar Shahian F. Comparison of acid salisylic 2% and betamethasone with topical fish oil in recovery of psoriasis signs. J Inflamm Dis. 2024;8(2):e155043. doi:

More by these authors

A KriplaniPubMedScholar
J ThulkarPubMedScholar
N AgrawalPubMedScholar
V KulshresthaPubMedScholar
AC AmminiPubMedScholar
Share
Cited by
Metrics